作者单位:
Department of Medical Oncology, Baylor University Medical Center, Texas Oncology and U.S
[1]
David Geffen School of Medicine, University of California Los AngelesLos Angeles,California,USA
[2]
Florida Precision Oncology, a division of 21st Century OncologyBoca Raton,Florida,USA
[3]
Breast Oncology, Division of Hematology/Oncology, University of Vermont Cancer Center, University
[4]
Personalized Healthcare, Product Development, Genentech, Inc.South San Francisco,California,USA
[5]
Sarah Cannon Research Institute and Tennessee OncologyNashville,Tennessee,USA
[6]
Georgetown Lombardi Comprehensive Cancer Center, Georgetown UniversityWashington,DC,USA
[7]
U.S. Medical Affairs, F. Hoffmann‐La RocheMississauga,Ontario,Canada
[8]
Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD
[9]
Helen Diller Family Comprehensive Cancer Center, University of California San FranciscoSan
[10]
U.S. Medical Affairs, Genentech, Inc.South San Francisco,California,USA
[11]
Inflammatory Breast Cancer Research FoundationWest Lafayette,Indiana,USA
[12]
Department of Internal Medicine, Rush University Medical CenterChicago,Illinois,USA
[13]
Hillman Cancer Center, University of Pittsburgh Medical CenterPittsburgh,Pennsylvania,USA
[14]
发布时间
2020-10-22